相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity
Lin Wu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2023)
Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway
Anwu Huang et al.
CARDIOVASCULAR THERAPEUTICS (2023)
Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT/Nrf2/ARE Pathway
Zhang Wei et al.
MEDIATORS OF INFLAMMATION (2023)
Nrf2 for protection against oxidant generation and mitochondrial damage in cardiac injury
Qin M. Chen
FREE RADICAL BIOLOGY AND MEDICINE (2022)
Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death
Chun-Yan Kong et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Bardoxolone Methyl Ameliorates Compression-Induced Oxidative Stress Damage of Nucleus Pulposus Cells and Intervertebral Disc Degeneration Ex Vivo
Yueyang Tian et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX
Atsushi Kuno et al.
CARDIOVASCULAR RESEARCH (2022)
MFG-E8 alleviates intervertebral disc degeneration by suppressing pyroptosis and extracellular matrix degradation in nucleus pulposus cells via Nrf2/TXNIP/NLRP3 axis
Haiwei Ma et al.
CELL DEATH DISCOVERY (2022)
Melatonin attenuates LPS-induced pyroptosis in acute lung injury by inhibiting NLRP3-GSDMD pathway via activating Nrf2/HO-1 signaling axis
Jia-Ying Kang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Targeting the NLRP3 inflammasome in cardiovascular diseases
Stefano Toldo et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Exosomal miR-17-5p from adipose-derived mesenchymal stem cells inhibits abdominal aortic aneurysm by suppressing TXNIP-NLRP3 inflammasome
Jiateng Hu et al.
STEM CELL RESEARCH & THERAPY (2022)
Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
Haiyan Li et al.
CHINESE MEDICINE (2022)
Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay
Leonardo Schirone et al.
CELLS (2022)
Nicorandil protects against coronary microembolization-induced myocardial injury by suppressing cardiomyocyte pyroptosis via the AMPK/ TXNIP/NLRP3 signaling pathway
Yangchun Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice
Araceli Lerida-Viso et al.
PHARMACOLOGICAL RESEARCH (2022)
Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway
Qianqian Jiang et al.
PHYTOMEDICINE (2022)
Natural compounds against doxorubicin-induced cardiotoxicity: A review on the involvement of Nrf2/AREsignaling pathway
Fatemeh Yarmohammadi et al.
PHYTOTHERAPY RESEARCH (2021)
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
Effimia Christidi et al.
CELL DEATH & DISEASE (2021)
Bardoxolone-Methyl Prevents Oxidative Stress-Mediated Apoptosis and Extracellular Matrix Degradation in vitro and Alleviates Osteoarthritis in vivo
Zhiying Pang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin
Kai Hou et al.
EBIOMEDICINE (2021)
Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms
Omeed Rahimi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway
Yifan Jia et al.
REDOX BIOLOGY (2020)
Enhanced Keap1-Nrf2/Trx-1 axis by daphnetin protects against oxidative stress-driven hepatotoxicity via inhibiting ASK1/JNK and Txnip/NLRP3 inflammasome activation
Hongming Lv et al.
PHYTOMEDICINE (2020)
Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway
Can Hu et al.
REDOX BIOLOGY (2020)
Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling
Yuqing Lin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis
Chun-Yan Wang et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure
Changhai Tian et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis
Yachun Han et al.
REDOX BIOLOGY (2018)
The NRF2 activator DH404 attenuates adverse ventricular remodeling postmyocardial infarction by modifying redox signalling
Kristen J. Bubb et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Bardoxolone methyl prevents the development and progression of cardiac and renal pathophysiologies in mice fed a high-fat diet
Danielle Camer et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
The thioredoxin antioxidant system
Jun Lu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl
Melanie P. Chin et al.
JOURNAL OF CARDIAC FAILURE (2014)
Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases
Eiji Yoshihara et al.
FRONTIERS IN IMMUNOLOGY (2014)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)